SemiLEDs Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SemiLEDs Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $43.01M | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | $5.18M | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | $5.98M | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | $7.05M | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | $4.74M | Nov 8, 2022 |
| FY2021 | Aug 31, 2020 | $6.07M | Nov 29, 2021 |
| FY2020 | Aug 31, 2019 | $5.90M | Nov 17, 2020 |
| FY2018 | Aug 31, 2018 | $1.95M | Nov 26, 2018 |
| FY2018 | May 31, 2018 | $2.00M | Nov 26, 2018 |
| FY2018 | Feb 28, 2018 | $1.54M | Nov 26, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $43.01M | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | $5.18M | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | $5.98M | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | $7.05M | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | $4.74M | Nov 8, 2022 |
| FY2020 | Aug 31, 2020 | $1.40M | Nov 17, 2020 |
| FY2020 | May 31, 2020 | $1.57M | Nov 17, 2020 |
| FY2020 | Feb 28, 2020 | $1.54M | Nov 17, 2020 |
| FY2020 | Nov 30, 2019 | $1.56M | Nov 17, 2020 |
| FY2020 | Aug 31, 2019 | $1.56M | Nov 17, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Aug 31, 2017 | $2.57M | Nov 29, 2017 |
| FY2017 | May 31, 2017 | $2.11M | Nov 29, 2017 |
| FY2017 | Feb 28, 2017 | $1.83M | Nov 29, 2017 |
| FY2017 | Nov 30, 2016 | $2.70M | Nov 29, 2017 |
| FY2017 | Aug 31, 2016 | $1.88M | Nov 29, 2017 |
| FY2017 | May 31, 2016 | $2.38M | Nov 29, 2017 |
| FY2017 | Feb 29, 2016 | $2.92M | Nov 29, 2017 |
| FY2017 | Nov 30, 2015 | $2.96M | Nov 29, 2017 |
| FY2016 | Aug 31, 2015 | $3.12M | Nov 21, 2016 |
| FY2016 | May 31, 2015 | $3.51M | Nov 21, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $2.43M | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | $1.05M | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | $1.01M | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | $1.40M | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | $1.03M | Nov 8, 2022 |
| FY2020 | Aug 31, 2020 | $108.0K | Nov 17, 2020 |
| FY2020 | May 31, 2020 | $416.0K | Nov 17, 2020 |
| FY2020 | Feb 28, 2020 | $548.0K | Nov 17, 2020 |
| FY2020 | Nov 30, 2019 | $518.0K | Nov 17, 2020 |
| FY2020 | Aug 31, 2019 | $329.0K | Nov 17, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | ($1.13M) | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | ($2.04M) | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | ($2.69M) | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | ($2.74M) | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | ($2.85M) | Nov 8, 2022 |
| FY2020 | Aug 31, 2020 | ($62.0K) | Nov 17, 2020 |
| FY2020 | May 31, 2020 | ($513.0K) | Nov 17, 2020 |
| FY2020 | Feb 28, 2020 | $348.0K | Nov 17, 2020 |
| FY2020 | Nov 30, 2019 | ($317.0K) | Nov 17, 2020 |
| FY2020 | Aug 31, 2019 | ($881.0K) | Nov 17, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | ($1.60M) | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | ($2.95M) | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | ($3.40M) | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | ($3.20M) | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | ($3.92M) | Nov 8, 2022 |
| FY2020 | Aug 31, 2020 | ($395.0K) | Nov 17, 2020 |
| FY2020 | May 31, 2020 | ($741.0K) | Nov 17, 2020 |
| FY2020 | Feb 28, 2020 | ($392.0K) | Nov 17, 2020 |
| FY2020 | Nov 30, 2019 | ($559.0K) | Nov 17, 2020 |
| FY2020 | Aug 31, 2019 | ($1.03M) | Nov 17, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $1.15M | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | $1.16M | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | $1.35M | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | $1.48M | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | $1.62M | Nov 8, 2022 |
| FY2021 | Aug 31, 2020 | $1.54M | Nov 29, 2021 |
| FY2020 | Aug 31, 2019 | $1.61M | Nov 17, 2020 |
| FY2019 | Aug 31, 2018 | $957.0K | Nov 20, 2019 |
| FY2018 | Aug 31, 2017 | $851.0K | Nov 26, 2018 |
| FY2017 | Aug 31, 2016 | $2.03M | Nov 29, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $2.87M | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | $2.89M | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | $3.06M | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | $3.31M | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | $3.61M | Nov 8, 2022 |
| FY2021 | Aug 31, 2020 | $2.81M | Nov 29, 2021 |
| FY2020 | Aug 31, 2019 | $2.79M | Nov 17, 2020 |
| FY2019 | Aug 31, 2018 | $3.18M | Nov 20, 2019 |
| FY2018 | Aug 31, 2017 | $3.71M | Nov 26, 2018 |
| FY2017 | Aug 31, 2016 | $4.77M | Nov 29, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $2.21M | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | ($365.0K) | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | ($984.0K) | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | ($1.51M) | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | ($1.74M) | Nov 8, 2022 |
| FY2021 | Aug 31, 2020 | ($1.00M) | Nov 29, 2021 |
| FY2020 | Aug 31, 2019 | ($3.55M) | Nov 17, 2020 |
| FY2019 | Aug 31, 2018 | ($1.18M) | Nov 20, 2019 |
| FY2018 | Aug 31, 2017 | ($2.11M) | Nov 26, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $569.0K | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | $123.0K | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | $200.0K | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | $280.0K | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | $118.0K | Nov 8, 2022 |
| FY2021 | Aug 31, 2020 | $271.0K | Nov 29, 2021 |
| FY2020 | Aug 31, 2019 | $127.0K | Nov 17, 2020 |
| FY2019 | Aug 31, 2018 | $341.0K | Nov 20, 2019 |
| FY2018 | Aug 31, 2017 | $150.0K | Nov 26, 2018 |
| FY2017 | Aug 31, 2016 | $821.0K | Nov 29, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $15.59M | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | $11.14M | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | $13.46M | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | $16.05M | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | $18.24M | Nov 8, 2022 |
| FY2021 | Aug 31, 2020 | $14.58M | Nov 29, 2021 |
| FY2020 | Aug 31, 2019 | $11.66M | Nov 17, 2020 |
| FY2019 | Aug 31, 2018 | $14.25M | Nov 20, 2019 |
| FY2018 | Aug 31, 2017 | $17.67M | Nov 26, 2018 |
| FY2017 | Aug 31, 2016 | $22.24M | Nov 29, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $12.81M | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | $8.89M | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | $12.26M | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | $12.56M | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | $13.61M | Nov 8, 2022 |
| FY2021 | Aug 31, 2020 | $12.01M | Nov 29, 2021 |
| FY2020 | Aug 31, 2019 | $9.87M | Nov 17, 2020 |
| FY2019 | Aug 31, 2018 | $9.25M | Nov 20, 2019 |
| FY2018 | Aug 31, 2017 | $9.85M | Nov 26, 2018 |
| FY2017 | Aug 31, 2016 | $10.59M | Nov 29, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $2.78M | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | $2.20M | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | $1.15M | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | $3.45M | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | $4.59M | Nov 8, 2022 |
| FY2021 | Aug 31, 2020 | $2.52M | Nov 29, 2021 |
| FY2020 | Aug 31, 2019 | $1.74M | Nov 17, 2020 |
| FY2019 | Aug 31, 2018 | $5.00M | Nov 20, 2019 |
| FY2017 | Aug 31, 2017 | $7.82M | Nov 29, 2017 |
| FY2017 | Aug 31, 2016 | $11.60M | Nov 29, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Aug 31, 2015 | $54.0K | Nov 21, 2016 |
| FY2015 | Aug 31, 2014 | $59.0K | Dec 15, 2015 |
| FY2014 | Aug 31, 2013 | $59.0K | Dec 12, 2014 |
| FY2013 | Aug 31, 2012 | $1.07M | Nov 26, 2013 |
| FY2012 | Aug 31, 2011 | $1.11M | Dec 13, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | ($189.81M) | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | ($188.68M) | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | ($186.65M) | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | ($183.96M) | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | ($181.21M) | Nov 8, 2022 |
| FY2021 | Aug 31, 2020 | ($178.36M) | Nov 29, 2021 |
| FY2020 | Aug 31, 2019 | ($177.82M) | Nov 17, 2020 |
| FY2019 | Aug 31, 2018 | ($174.25M) | Nov 20, 2019 |
| FY2018 | Aug 31, 2017 | ($171.27M) | Nov 26, 2018 |
| FY2017 | Aug 31, 2016 | ($167.18M) | Nov 29, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $2.59M | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | $1.67M | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | $2.57M | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | $4.27M | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | $4.83M | Nov 8, 2022 |
| FY2021 | Aug 31, 2020 | $2.83M | Nov 29, 2021 |
| FY2020 | Aug 31, 2019 | $1.36M | Nov 17, 2020 |
| FY2019 | Aug 31, 2018 | $3.42M | Nov 20, 2019 |
| FY2018 | Aug 31, 2017 | $3.58M | Nov 26, 2018 |
| FY2018 | Aug 31, 2016 | $6.03M | Nov 26, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $1.71M | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | $3.72M | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | $6.37M | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | $6.93M | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | $7.68M | Nov 8, 2022 |
| FY2021 | Aug 31, 2020 | $7.66M | Nov 29, 2021 |
| FY2020 | Aug 31, 2019 | $6.35M | Nov 17, 2020 |
| FY2019 | Aug 31, 2018 | $2.35M | Nov 20, 2019 |
| FY2018 | Aug 31, 2017 | $2.73M | Nov 26, 2018 |
| FY2017 | Aug 31, 2016 | $2.91M | Nov 29, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 0 | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | 0 | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | 0 | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | 0 | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | 0 | Nov 8, 2022 |
| FY2012 | Aug 31, 2012 | (1) | Dec 13, 2012 |
| FY2012 | Aug 31, 2011 | 0 | Dec 13, 2012 |
| FY2012 | Aug 31, 2010 | 0 | Dec 13, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 0 | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | 0 | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | 0 | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | 0 | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | 0 | Nov 8, 2022 |
| FY2012 | Aug 31, 2012 | (1) | Dec 13, 2012 |
| FY2012 | Aug 31, 2011 | 0 | Dec 13, 2012 |
| FY2012 | Aug 31, 2010 | 0 | Dec 13, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 8.23M | Nov 28, 2025 |
| FY2025 | Aug 31, 2024 | 7.21M | Nov 28, 2025 |
| FY2024 | Aug 31, 2023 | 4.94M | Nov 27, 2024 |
| FY2023 | Aug 31, 2022 | 4.83M | Nov 28, 2023 |
| FY2022 | Aug 31, 2021 | 4.46M | Nov 8, 2022 |
| FY2021 | Aug 31, 2020 | 4.01M | Nov 29, 2021 |
| FY2020 | Aug 31, 2019 | 3.59M | Nov 17, 2020 |
| FY2019 | Aug 31, 2018 | 3.56M | Nov 20, 2019 |
| FY2018 | Aug 31, 2017 | 3.54M | Nov 26, 2018 |
| FY2017 | Aug 31, 2016 | 3.52M | Nov 29, 2017 |